PP Sanna, T Kawamura, J Chen, GF Koob, AJ Roberts, LF Vendruscolo, and V Repunte-Canonigo. “11β-hydroxysteroid dehydrogenase inhibition as a new potential therapeutic target for alcohol abuse.” Translational Psychiatry, March 15, 6:e760. Abstract
FP Varodayan, G de Guglielmo, ML Logrip, O George, and M Roberto. “Alcohol dependence disrupts amygdalar L-type voltage-gated calcium channel mechanisms.” Journal of Neuroscience, 37, Pp. 4593-4603. Abstract
P Metten, JP Schlumbohm, LC Huang, GD Greenberg, WR Hack, SE Spence, and JC Crabbe. “An alcohol withdrawal test battery measuring multiple behavioral symptoms in mice.” Alcohol, 68, may, Pp. 19-35. Abstract
NM Zahr, A Pfefferbaum, and EV Sullivan. “Alcohol’s Effects on the Brain: Neuroimaging Results in Humans and Animal Models.” Alchol Research, 38, Pp. 183-206. Abstract
Hitzemann R, Oberbeck D, Iancu O, Darakjian P, McWeeney S, Spence S, Schlumbohm J, Metten P, and Crabbe J. “Alignment of the transcriptome with individual variation in animals selectively bred for High Drinking-In-the-Dark (HDID)..” Alcohol, 60, Pp. 115-120. Publisher’s Version Abstract
RA Mangieri, EY Maier, TR Buske, AW Lasek, and RA Morrisett. “Anaplastic lymphoma kinase is a regulator of alcohol consumption and excitatory synaptic plasticity in the nucleus accumbens shell.” Frontiers in Pharmacology, 2017, 8, Pp. 533. Abstract
Dutton JW 3rd, Chen H, You C, Brodie MS, and Lasek AW. “Anaplastic lymphoma kinase regulates binge-like drinking and dopamine receptor sensitivity in the ventral tegmental area..” Addiction Biology, 22, Pp. 665-678. Publisher’s Version Abstract
FP Varodayan, M Bajo, N Soni, G Luu, SG Madamba, P Schweitzer, and M Roberto. “Chronic alcohol exposure disrupts CB1 regulation of GABAergic transmission in the rat basolateral amygdala.” Addiction Biology, 22, Pp. 766-778. Abstract
GM McCarthy, CR Bridges, YA Blednov, and RA Harris. “ CNS cell-type localization and LPS response of TLR signaling pathways.” F1000 Research, 6, Pp. 1144. Abstract
W. J. Giardino, E. D. Rodriguez, M. L. Smith, M. M. Ford, D. Galili, S. H. Mitchell, A. Chen, and A. E. Ryabinin. “Control of chronic excessive alcohol drinking by genetic manipulation of the Edinger-Westphal nucleus urocortin-1 neuropeptide system.” Translational Psychiatry, 7, 1, Pp. e1021. Abstract
MB Pomrenze, TL Fetterly, DG Winder, and RO Messing. “The corticotropin releasing factor receptor 1 in alcohol use disorder: still a valid drug target?.” Alcoholism: Clinical and Experimental Research, 41, 12, Pp. 1986-1999. Abstract
M Roberto, SR Spierling, D Kirson, and EP Zorrilla. “Corticotropin-releasing factor (CRF) and addictive behaviors.” International Review of Neurobiology, Pp. 136:5-51. Abstract
FP Varodayan, D Correia, D Kirson, S Khom, CS Oleata, G Luu, P Schweitzer, and M Roberto. “CRF modulates glutamate transmission in the central amygdala of naïve and ethanol-dependent rats.” Neuropharmacology, 125, Pp. 418-428. Abstract
CT Tulisiak, RA Harris, and I Ponomarev. “DNA modifications in models of alcohol use disorders.” Alcohol, May, 60, Pp. 19-30. Abstract
CT Tulisiak, RA Harris, and I Ponomarev. “DNA modifications in models of alcohol use disorders.” Alcohol, 60, Pp. 19-30. Abstract
Colville AM, Iancu OD, Oberbeck DL, Darakjian P, Zheng CL, Walter NA, Harrington CA, Searles RP, McWeeney S, and Hitzemann RJ. “Effects of selection for ethanol preference on gene expression in the nucleus accumbens of HS-CC mice..” Genes Brain and Behavior, 16, 4, Pp. 462-471. Publisher’s Version Abstract
RD Mayfield. “Emerging roles for ncRNAs in alcohol use disorders.” Alcohol, 60, May 2017, Pp. 31-39. Abstract
Mahnke AH, Miranda RC, and Homanics GE. “Epigenetic mediators and consequences of excessive alcohol consumption..” Alcohol, 60, Pp. 1-6. Publisher’s Version Abstract
BJ Vandegrift, C You, R Satta, MS Brodie, and AW Lasek. “Estradiol increases the sensitivity of ventral tegmental area dopamine neurons to dopamine and ethanol.” PLoS One. Abstract
Le Berre AP, Fama R, and Sullivan EV. “Executive functions, memory, and social cognitive deficits and recovery in chronic alcoholism: a critical review to inform future research..” Alcoholism: Clinical and Experimental Research, 41, Pp. 1432-1443. Publisher’s Version Abstract
BJ Mason, S Quello, and F Shadan. “Gabapentin for the treatment of alcohol use disorder.” Expert Opinion on Investigational Drugs, 27, 1, Pp. 113-124. Abstract
Dir AL, Bell RL, Adams ZW, and Hulvershorn LA. “Gender differences in risk factors for adolescent binge drinking and implications for intervention and prevention..” Frontiers in Psychiatry, 8, Pp. 289. Publisher’s Version Abstract
JN McClintick, WJ McBride, RL Bell, ZM Ding, Y Liu, X Xuei, and HJ Edenberg. “Gene expression changes in the ventral hippocampus and medial prefrontal cortex of adolescent alcohol-preferring (P) rats following binge-like alcohol drinking.” Alcohol, 68, May 2018, Pp. 37-47. Abstract
AS Warden and RD Mayfield. “Gene expression profiling in the human alcoholic brain.” Neuropharmacology, 122, Pp. 161-174. Abstract
R. Adron Harris, Michal Bajo, Richard L. Bell, Yuri A. Blednov, Florence P. Varodayan, Jay M. Truitt, Giordano de Guglielmo, Amy W. Lasek, Marian L. Logrip, Leandro F. Vendruscolo, Amanda J. Roberts, Edward Roberts, Olivier George, Jody Mayfield, Timothy R. Billiar, David J. Hackam, R. Dayne Mayfield, George F. Koob, Marisa Roberto, and Gregg E. Homanics. “Genetic and Pharmacologic Manipulation of TLR4 Has Minimal Impact on Ethanol Consumption in Rodents.” The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 37, 5, Pp. 1139–1155. Abstract
LM McCracken, DC Lowes, MC Salling, C Carreau-Vollmer, NN Odean, YA Blednov, H Betz, RA Harris, and NL Harrison. “Glycine receptor α3 and α2 subunits mediate tonic and exogenous agonist-induced currents in forebrain.” Proceedings of the National Academy of Sciences USA, 114, 34, Pp. E7179–E718. Abstract
Crabbe JC. “High Drinking in the Dark (HDID) mice are sensitive to the effects of some clinically relevant drugs to reduce binge-like drinking..” Pharmacology Biochemistry and Behavior, 169, Pp. 55-62. Publisher’s Version Abstract
JM Truitt, YA Blednov, JM Benavidez, M Black, O Ponomareva, J Law, M Merriman, S Horani, K Jameson, AW Lasek, RA Harris, and RD Mayfield. “Inhibition of IKKβ reduces ethanol consumption in C57BL/6J mice.” eNeuro, 3(5), Pp. 0256-16. Abstract
I Ponomarev, CE Stelly, H Morikawa, YA Blednov, RD Mayfield, and RA Harris. “ Mechanistic insights into epigenetic modulation of ethanol consumption.” Alcohol, 60, Pp. 95-101. Abstract
GM McCarthy, SP Farris, YA Blednov, RA Harris, and RD Mayfield. “Microglial-specific transcriptome changes following chronic alcohol consumption.” Neuropharmacology, 128, January 2018, Pp. 416-424. Abstract
Chen H, He D, and Lasek AW. “Midkine in the mouse ventral tegmental area limits ethanol intake and Ccl2 gene expression..” Genes Brain and Behavior, 16, Pp. 699-708. Publisher’s Version Abstract
Blednov YA, Borghese CM, Ruiz CI, Cullins MA, Da Costa A, Osterndorff-Kahanek EA, Homanics GE, and Harris RA. “Mutation of the inhibitory ethanol site in GABA(A) ρ1 receptors promotes tolerance to ethanol-induced motor incoordination..” Neuropharmacology , 123, Pp. 201-209. Publisher’s Version Abstract
JM Reno, N Thakore, LK Cormack, T Schallert, RL Bell, WT Maddox, and CL Duvauchelle. “Negative affect-associated USV acoustic characteristics predict future excessive alcohol drinking and alcohol avoidance in male P and NP rats.” Alcoholism: Clinical and Experimental Research, 41, Pp. 786-797. Abstract
Jody Mayfield and R. Adron Harris. “The Neuroimmune Basis of Excessive Alcohol Consumption.” Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 42, 1, Pp. 376.
Borghese CM, Herman M, Snell LD, Lawrence KJ, Lee HY, Backos DS, Vanderlinden LA, Harris RA, Roberto M, Hoffman PL, and Tabakoff B. “Novel molecule exhibiting selective affinity for GABAA receptor subtypes..” Scientific Reports, 7, Pp. 6230. Publisher’s Version Abstract
Colin N. Haile and Therese A. Kosten. “The peroxisome proliferator-activated receptor alpha agonist fenofibrate attenuates alcohol self-administration in rats.” Neuropharmacology, 116, Pp. 364–370. Abstract
NM Zahr, A Pfefferbaum, and Sullivan EV. “Perspectives on fronto-fugal circuitry from human imaging of alcohol use disorders.” Neuropharmacology, 122, Pp. 189-200. Abstract
FP Varodayan, ML Logrip, and M Roberto. “P/Q-type voltage-gated calcium channels mediate the ethanol and CRF sensitivity of central amygdala GABAergic synapses..” Neuropharmacology, 125, Pp. 197-206. Abstract
Hashimoto JG, Gavin DP, Wiren KM, Crabbe JC, and Guizzetti M. “Prefrontal cortex expression of chromatin modifier genes in male WSP and WSR mice changes across ethanol dependence, withdrawal, and abstinence..” Alcohol, 60, Pp. 83-94. Publisher’s Version Abstract
Bell RL, Hauser SR, Liang T, Sari Y, Maldonado-Devincci A, and Rodd ZA. “Rat animal models for screening medications to treat alcohol use disorders..” Neuropharmacology , 122, Pp. 201-243. Publisher’s Version Abstract
Ding ZM, Ingraham CM, Hauser SR, Lasek AW, Bell RL, and McBride WJ. “Reduced Levels of mGlu2 Receptors within the prelimbic cortex are not associated with elevated glutamate transmission or high alcohol drinking..” Alcoholism: Clinical and Experimental Research, 41, Pp. 1896-1906. Publisher’s Version Abstract
Arefin TM, Mechling AE, Meirsman AC, Bienert T, Hübner NS, Lee HL, Ben Hamida S, Ehrlich A, Roquet D, Hennig J, von Elverfeldt D, Kieffer BL, and Harsan LA. “Remodeling of sensorimotor brain connectivity in Gpr88-deficient mice..” Brain Connectivity, 7, 8, Pp. 526-540. Publisher’s Version Abstract
Blednov YA, Black M, Benavidez JM, Da Costa A, Mayfield J, and Harris RA. “Sedative and motor incoordination effects of ethanol in mice lacking CD14, TLR2, TLR4, or MyD88..” Alcoholism: Clinical and Experimental Research, 41, 3, Pp. 531-540. Publisher’s Version Abstract
Rafael Renteria, Esther Y. Maier, Tavanna R. Buske, and Richard A. Morrisett. “Selective alterations of NMDAR function and plasticity in D1 and D2 medium spiny neurons in the nucleus accumbens shell following chronic intermittent ethanol exposure.” Neuropharmacology, 112, Pt A, Pp. 164–171. Abstract
Marian L. Logrip, Christopher Oleata, and Marisa Roberto. “Sex differences in responses of the basolateral-central amygdala circuit to alcohol, corticosterone and their interaction.” Neuropharmacology, 114, Pp. 123–134. Abstract
Ji X, Saha S, Gao G, Lasek AW, Homanics GE, Guildford M, Tapper AR, and Martin GE. “The sodium channel β4 auxiliary subunit selectively controls long-term depression in core nucleus accumbens medium spiny neurons..” Frontiers in Cellular Neuroscience, 11, Pp. 17. Publisher’s Version Abstract
M Roberto and FP Varodayan. “Synaptic targets: Chronic alcohol actions.” Neuropharmacology., Aug 1, 122, Pp. 85-99. Abstract
CP Pratt, DA Kuljis, GE Homanics, J He, D Kolodieznyi, S Dudem, MA Hollywood, AL Barth, and MP Bruchez. “Tagging of endogenous BK channels with a fluorogen-activating peptide reveals β4-mediated control of channel clustering in cerebellum.” Frontiers in Cellular Neuroscience, 11, Pp. 337. Abstract
JG Bray, AJ Roberts, and DL Gruol. “Transgenic mice with increased astrocyte expression of CCL2 show altered behavioral effects of alcohol. Neuroscience.” Neuroscience, 354, Pp. 88-100. Abstract
Laura-Joy Boulos, Emmanuel Darcq, and Brigitte Lina Kieffer. “Translating the Habenula-From Rodents to Humans.” Biological Psychiatry, 81, 4, Pp. 296–305. Abstract